These data suggest that SF3B1 mutations affect the splicing of MAP3K7, which, at least in part, the results in hyperactivation of NF-κB signaling, which is associated with MDS pathogenesis. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.